Muscle Pharm Corporation (MSLPQ)

[BAR123]

It is doing everything a growth stock should be doing. Low float + increased earnings and rev = much higher stock price. Remember that the stock market is a prediction of future results so we are $6 months ahead of ourselves minus the SEC issue and uplift to Nas. So maybe we should really be in the $18 range right now with these issues gone away. When they release earning in a few weeks and up guidance based on new product releases and partnerships, that could take us to $20+ by the end of the year. Take the isuues out of the way maybe we go to $25. Time will tell but stay on track until the company changes the outlook.